tm logo
CANOPY Y IMMUNO-THERAPEUTICS
Live/Registered
REGISTERED

on 12 Oct 2021

Last Applicant/ Owned by

Serial Number

79282685 filed on 13th Feb 2020

Registration Number

6513427 registered on 12th Oct 2021

in the Principal Register

Correspondent Address

ROY D GROSS

ROY D GROSS

50 WASHINGTON STREET, SUITE 737/745

NORWALK, CT 06854

Filing Basis

No Filing Basis

Disclaimer

NO DATA

CANOPY Y IMMUNO-THERAPEUTICS

Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials for the treatment of autoimmune diseases and disorders; Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials for the treatment of autoimmune diseases, by eliminating specific lymphocytes' lineages or modulating the immune res Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials for the treatment of autoimmune diseases and disorders; Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials for the treatment of autoimmune diseases, by eliminating specific lymphocytes' lineages or modulating the immune response using a variety of organic compounds and recombinant proteins; Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials that modulate the immune system by recombinant proteins that contain a targeting moiety and an effect or moiety to eliminate specific lymphocytes' lineages and attenuate or block antibody creation and antigen-specific immune response in autoimmune diseases for the treatment of autoimmune diseases and disorders; Pharmaceutical recombinant proteins and substances not related to pharmaceuticals and clinical trials that modulate the immune system by recombinant proteins that contain a targeting moiety and an effect or moiety to eliminate specific lymphocytes lineages and attenuate or block the creation of the antibodies IgG, IgE or IgA and antigen-specific immune response in autoimmune diseases for the treatment of autoimmune diseases and disorders; Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials with potential immunomodulation activity to treat under and over responsiveness of the immune system for the treatment of autoimmune diseases and disorders

Mark Details


Serial Number

No 79282685

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 08364-T0001A

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

05.01.25 -

Other trees or bushes

27.01.03 -

Letters or numerals, including punctuation, forming representations of plants or parts of plants

Legal History


Show more

Status DateAction Taken
10th Apr 2022FINAL DECISION TRANSACTION PROCESSED BY IB
19th Mar 2022FINAL DISPOSITION NOTICE SENT TO IB
18th Mar 2022FINAL DISPOSITION PROCESSED
12th Jan 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12th Oct 2021REGISTERED-PRINCIPAL REGISTER
03rd Oct 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
15th Sep 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15th Sep 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27th Jul 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27th Jul 2021PUBLISHED FOR OPPOSITION